Daruvir – Darunavir 300mg Tablets (Generic Prezista)

Daruvir – Darunavir 300mg Tablets (Generic Prezista)

Brand Name: Daruvir
Strength: 300mg
Contents: Darunavir 300mg Tablets
Form: Tablets
Manufacturer Cipla
Other Brand Name: Prezista
Pricing: Pack of 60 Tabs

Indications
DARUVIR co-administered with ritonavir (darunavir/rtv) and with other antiretroviral agents, are indicated for the treatment of HIV-1 infection in antiretroviral treatment-experienced adult patients, such as those with HIV-1 strains resistant to more than one protease inhibitor.

This indication is based on analyses of plasma HIV RNA levels and CD4+ cell counts from controlled Phase 3 trials of 48 weeks duration in antiretroviral treatment-experienced patients and controlled Phase 2 trials of 96 weeks duration in clinically advanced, treatment-experienced adult patients.

In treatment-experienced adult patients, the following points should be considered when initiating therapy with DARUVIR :

  • Treatment history and, when available, genotypic or phenotypic testing should guide the use of DARUVIR.
  • The use of other active agents with DARUVIR is associated with a greater likelihood of treatment response.

DARUVIR tablets are contraindicated with drugs like Alfuzosin, Dihydroergotamine, ergonovine, ergotamine, methylergonovine, Cisapride, Pimozide, Orally administered Midazolam, Triazolam, Lovastatin, Simvastatin, Rifampin, Sildenafil for treatment of pulmonary arterial hypertension.